학술논문

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Document Type
Artikel
Source
Annals of neurology. 87(5):688-699
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1531-8249